Researchers have discovered how unstructured segments of surface proteins regulate the biological function of a cell. Their ...
Get insights on the upcoming HOPE 3 phase 3 trial, key endpoints, and investment risks for CAPR. Learn what to watch in ...
Cisco software includes a compiler that enables quantum workloads to run in distributed environments, including multivendor ...
At HR Tech 2025, five priority areas emerged to guide HR leaders as they modernize practices and build more agile, resilient ...
Two experts discussed innovative trial designs in rare disease research, common challenges and the potential of AI to enhance research.
Already approved for progressive multiple sclerosis, ocrelizumab in a second phase 3 study demonstrates meaningful clinical ...
By integrating digital tools like ePRO, we can bridge the gap between patients’ lived experiences and clinical research.
The FDA in September issued two rejections for spinal muscular atrophy therapies—both linked to manufacturing problems—and ...
MedPage Today on MSN
Trial Makes the Case for Treating Knee Osteoarthritis With Radiation
An unmet need in the treatment of knee OA exists between conservative care and invasive surgery, Kim explained. And while low ...
DSPM helps secure sensitive cloud data by continuously monitoring and proactively protecting it, unlike traditional tools ...
Zacks Investment Research on MSN
Can CYTK Clinch a Potential FDA Nod for Its Cardiovascular Drug?
It has been a roller coaster ride for Cytokinetics, Inc. CYTK so far in 2025. While the delay in FDA approval of its lead candidate aficamten for the treatment of patients with obstructive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results